A comparative efficacy trial in Germany in infants who received either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell …

K Stehr, JD Cherry, U Heininger, S Schmitt-Grohé… - …, 1998 - publications.aap.org
Background. The goal of the trial was to determine the efficacy of a multicomponent acellular
pertussis vaccine against Bordetella illnesses in comparison with a whole-cell product and …
被引用次数：244 相关文章

[引用][C] A comparative efficacy trial in Germany in infants who received either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle …

K STEHR, JD CHERRY, U HEININGER… - Pediatrics …, 1998 - pascal-francis.inist.fr
A comparative efficacy trial in Germany in infants who received either the Lederle/Takeda
acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP …

A comparative efficacy trial in Germany in infants who received either the Lederle/Takeda...

K Stehr, JD Cherry - Pediatrics, 1998 - elibrary.ru
Presents a study to determine the efficacy of a multicomponent acellular pertussis vaccine
against Bordatella illnesses in comparison with a whole-cell product and DT in Germany …

A comparative efficacy trial in Germany in infants who received either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell …

K Stehr, JD Cherry, U Heininger, S Schmitt-Grohé… - 1998 - cabidigitallibrary.org
A randomized, double-blind clinical trial was conducted in Germany to determine the
efficacy of a multicomponent acellular pertussis vaccine against Bordetella illnesses in …
[PDF] researchgate.net

[PDF][PDF] A Comparative Efficacy Trial in Germany in Infants Who Received Either the Lederle/Takeda Acellular Pertussis Component DTP (DTaP) Vaccine, the Lederle …

K Stehr, JD Cherry, U Heininger, S Schmitt-Grohé… - …, 1998 - researchgate.net
Background. The goal of the trial was to determine the efficacy of a multicomponent acellular
pertussis vaccine against Bordetella illnesses in comparison with a whole-cell product and …
[PDF] academia.edu

[PDF][PDF] A Comparative Efficacy Trial in Germany in Infants Who Received Either the Lederle/Takeda Acellular Pertussis Component DTP (DTaP) Vaccine, the Lederle …

K Stehr, JD Cherry, U Heininger, S Schmitt-Grohé… - PEDIATRICS, 1998 - academia.edu
Background. The goal of the trial was to determine the efficacy of a multicomponent acellular
pertussis vaccine against Bordetella illnesses in comparison with a whole-cell product and …

A comparative efficacy trial in Germany in infants who received either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell …

K Stehr, JD Cherry, U Heininger, S Schmitt-Grohé… - Pediatrics, 1998 - europepmc.org
Background The goal of the trial was to determine the efficacy of a multicomponent acellular
pertussis vaccine against Bordetella illnesses in comparison with a whole-cell product and …

A comparative efficacy trial in Germany in infants who received either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell …

K Stehr, JD Cherry, U Heininger… - …, 1998 - pubmed.ncbi.nlm.nih.gov
Background The goal of the trial was to determine the efficacy of a multicomponent acellular
pertussis vaccine against Bordetella illnesses in comparison with a whole-cell product and …

A Comparative Efficacy Trial in Germany in Infants Who Received Either the Lederle/Takeda Acellular Pertussis Component DTP (DTaP) Vaccine, the Lederle Whole …

K Stehr, JD Cherry, U Heininger, S Schmitt-Grohé… - Pediatrics, 1998 - cir.nii.ac.jp
抄録< jats: p> Background. The goal of the trial was to determine the efficacy of a
multicomponent acellular pertussis vaccine against Bordetella illnesses in comparison with …

A comparative efficacy trial in Germany in infants who received either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell …

K Stehr, JD Cherry, U Heininger, S Schmitt-Grohé… - Pediatrics, 1998 - edoc.unibas.ch
BACKGROUND. The goal of the trial was to determine the efficacy of a multicomponent
acellular pertussis vaccine against Bordetella illnesses in comparison with a whole-cell …